What is the scoring for stage 6 on the Functional Assessment Staging Test (FAST) scale?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FAST Stage 6 Scoring

Stage 6 on the Functional Assessment Staging Test (FAST) represents severe dementia with significant impairment in basic activities of daily living (BADLs), though the provided evidence does not contain the specific detailed scoring criteria for this individual stage.

What the Evidence Shows

The FAST scale is based on the Global Deterioration Scale for typical Alzheimer's disease dementia and uses a structured interview format, typically administered by interviewing the care partner 1. The scale:

  • Consists of items rated on a 4-point scale (0,1,2,3) where:

    • 0 = performs task normally
    • 1 = mild impairment
    • 2 = moderate impairment
    • 3 = severe impairment
  • Overall range is 0-60, progressing from independent to dependent functioning 1

  • Symptoms typically progress in sequence in typical AD dementia, though atypical dementias may not follow this pattern 1

Stage 6 Context

Recent research indicates that Stage 6 represents a transition point in severe dementia where cognitive testing becomes less discriminatory. When differentiating FAST Stage 5 from Stage 6, cognitive assessments show only moderate discrimination (AUC = 0.77), with broader domain involvement across multiple functional areas 2.

Stage 6 is often used as a benchmark for determining preliminary eligibility for palliative or hospice care in patients with severe dementia 1.

Clinical Application

The FAST has been validated in both primary and specialty care settings and can be administered by clinical or non-clinical staff 1. It is particularly useful for:

  • Tracking BADLs across the full spectrum of dementia stages
  • Longitudinal monitoring as disease progresses
  • Care planning decisions in advanced dementia 3

Common pitfall: The evidence provided does not include the complete FAST staging criteria with specific descriptors for each stage. For the detailed Stage 6 criteria, clinicians should reference the complete FAST scale available through the Alzheimer's Association resources 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.